Proton Therapy for Breast, Prostate, and Leptomeningeal Disease—Some Answers, but Questions Persist
Emerging evidence in breast cancer, prostate cancer, and leptomeningeal disease addresses important questions regarding the role of proton therapy. Here, we review selected studies that provide clinical insights to inform patient selection, risk stratification, and future research.
Authors
- Bethany Marie Anderson (ORCID: https://orcid.org/0000-0001-7645-2159)
- Robert Timothy Dess (ORCID: https://orcid.org/0000-0003-2331-3758)
- Salma K. Jabbour (ORCID: https://orcid.org/0000-0001-8200-5371)
- Lakshmi Rekha Narra (ORCID: https://orcid.org/0000-0003-2058-873X)
- Michelle M. Kim
Institutions
- Rutgers, The State University of New Jersey (US)
- University of Wisconsin–Madison (US)
- University of Michigan (US)
- Rutgers Cancer Institute (US)
Publication Details
- Journal
- International Journal of Radiation Oncology*Biology*Physics
- Published
- 2026-10-14
- DOI
- https://doi.org/10.1016/j.ijrobp.2026.08.002
- Primary Topic
- Radiation Therapy and Dosimetry
- Type
- article
- Field-Weighted Citation Impact
- 0.00